Zoetis Inc. announced the addition of Ester Banque as Executive Vice President and President, U.S. Operations, for the company, effective July 10, 2023. Ms. Banque is an accomplished global senior executive with over 30 years of experience in health sciences with top tier pharmaceutical companies. Ester will be a member of the Zoetis Executive team and report to Chief Executive Officer Kristin Peck.

In this role, Ms. Banque will have responsibility for the company’s U.S. commercial operations, continuing to broaden and expand the company’s key franchises and shape the market for future innovation - providing exceptional experiences for companion animal and livestock customers. In connection with Ester’s appointment, William (“Chip”) Dorsey, interim Head of U.S. Operations since February 2023, will continue in his finance leadership role and be a resource to Ms. Banque as she onboards. Most recently, Ester has served as Senior Vice President and General Manager of Bristol Myers-Squibb’s U.S. Hematology & Cell Therapy Business, where she led the transformation of a portfolio -- from major losses of patent exclusivity to accelerating the launch of five products -- while managing a $14 billion1 P&L for the company.

Before joining Bristol Myers-Squibb, Ester spent 25 years at Novartis where she held a variety of senior commercial positions and spearheaded the most successful product launch in the company’s history, before taking on the role of General Manager of Oncology, Germany.